DNA replication is a fundamental cellular process necessary to ensure the faithful transmission of genetic information. In eukaryotes, three highly conserved DNA polymerases, polymerase epsilon, delta, and alpha, act in concert at the replication fork. Polymerase epsilon (Pol ε) is the major enzyme responsible for the synthesis of the leading strand 1 and is consequently an essential gene. 2 POLE encodes the catalytic subunit of Pol ε (POLE1), and somatic and germline missense mutations affecting the proofreading domain of POLE1 have been associated with colon and endometrial cancer. [3] [4] [5] [6] Microcephalic primordial dwarfism comprises a group of prenatal-onset extreme growth disorders characterized by intrauterine growth retardation, short stature, and microcephaly. Genes involved in cell cycle progression, including multiple components of the replication licensing machinery, have been identified as monogenic causes of this disorder. [7] [8] [9] [10] [11] As the molecular basis for many affected individuals remains to be determined, we performed whole-genome sequencing studies to identify further genes and facilitate more comprehensive diagnosis.
Whole-genome sequencing (WGS) of 48 individuals with microcephalic primordial dwarfism identified heterozygous POLE (GenBank: NM_006231.3) loss-of-function (LoF) variants in three subjects (P1, P3, P4; Table 1 ). These LoF variants were significantly enriched in our cohort compared to a control WGS dataset (GnomAD, 12 p ¼ 5.1 3 10 À5 , Fisher's exact test, Table S1 ). As these variants were present in the unaffected parents, the WGS data were further evaluated and a second rare intronic variant in POLE identified, c.1686þ32C>G (dbSNP: rs762985435). This was present in trans with the LoF mutation in all three probands (Table 1) . Targeted sequencing of POLE and interrogation of existing whole-exome sequencing (WES) data in additional cases of primordial dwarfism identified five additional subjects compound heterozygous for LoF alleles and the c.1686þ32C>G variant (P5-P9, Table 1 ). Notably, a clinical diagnosis of IMAGe syndrome (GeneReviews in Web Resources) (MIM: 614732) had been considered in individuals P1 and P3, with adrenal failure also reported in P5, P6, and P7. We therefore investigated cases of IMAGe syndrome drawn from other cohorts without an existing molecular diagnosis (i.e., CDKN1C mutation negative). These included three previously published IMAGe-affected case subjects. 13, 14 Analysis of their WGS data identified additional POLE LoF variants inherited in trans with the intronic variant in individuals P11-P15 (Table 1) . The c.1686þ32C>G variant was part of a common haplotype in all individuals where WES/WGS performed, extending over 921 kbp ( Figure S2 , chr12:132341818-133263107, GRCh38). In P10 a missense variant (c.3019G>C) encoding a p.Ala1007Pro substitution was found, at a residue conserved to yeast ( Figure S1 ) within the polymerase domain of the protein ( Figure 1 ). All variants identified were sufficiently rare (MAF < 0.0001 12 ) and, where DNA available, segregation in families was consistent with an autosomal recessively inherited disorder (Table 1) . Phenotypically, affected individuals had severe growth failure of prenatal onset ( Figure 2 , Table S2 ). IUGR was present in all case subjects (birth weight was À3.0 5 0.8 SD) with significant short stature evident postnatally (height À8.1 5 2.4 SD). While head circumference was also significantly reduced (OFC À5.4 5 1.5 SD), this was less severe, resulting in a relative macrocephaly. Those affected had a common facial appearance with micrognathia, crowded dentition, long thin nose, short wide neck, and small, low-set, posteriorly rotated ears (Figure 2 ). 12 individuals had adrenal insufficiency and all affected males had genitourinary abnormalities including bilateral cryptorchidism and/or hypospadias, with the majority of case subjects fulfilling clinical criteria for IMAGe syndrome (GeneReviews in Web Resources; Table 2, Table S3 , Supplemental Note). Abbreviations: ID, individual number; Fam, family number; Mat, maternal; Pat, paternal; n/a, not available. All subjects harbored a loss-of-function mutation in combination with an intronic variant on the alternate allele identified as part of a shared haplotype and found to alter splicing in RNA studies. MAF indicates minor allele frequency in European (non-Finnish) population observed in gnomAD. None of the variants were present in any Non-European population in gnomAD.
Osteopenia and developmental dysplasia of the hip (DDH) were frequently observed and café-au-lait patches were notably present in a third of individuals. A single homozygous intronic variant (c.4444þ3A>G) in POLE has previously been reported to be associated with immunodeficiency, lymphopenia, and short stature (facial dysmorphism, immunodeficiency, livedo, and short stature, aka FILS syndrome [MIM: 615139]). 15, 16 Five affected individuals identified in this study also had increased susceptibility to respiratory tract infections, with lymphocyte subset deficiencies and/or IgM hypogammaglobinemia identified in P1, P3, P4, P8, P9, P14, and P15 ( Table 2, Table S4 ). Deficiency of natural killer cells was present in P1, P3, and P8. P1 had the most profound immunodeficiency, developing CMV pneumonitis and then subsequently developed EBV haemophagocytic lymphohistiocytosis, requiring an allogeneic bone marrow transplant. Notably, this subject's sister (P2), who had the same compound heterozygous POLE mutations, died at 22 months from HSV infection. Therefore, our findings establish that the phenotype spectrum of biallelic POLE mutations extends from IMAGe syndrome to include immunodeficiency, in line with the phenotype and pathogenicity of the previously reported c.4444þ3A>G mutation. 15, 16 To establish whether the c.1686þ32C>T variant affected the POLE transcript, RNA studies were performed on primary fibroblast lines derived from two subjects (P1, P3). RT-PCR using primers spanning POLE intron 15 demonstrated the presence of a larger PCR product (Figure 3 ), which capillary sequencing established to be due to retention of part of intron 15 within POLE transcripts ( Figure S3 ). A minigene assay was then performed to assess splicing of this genomic segment and to directly confirm the contribution of the c.1686þ32C>G variant. This demonstrated that the c.1686þ32C>G variant markedly impaired splicing of the usual exon 15 splice donor site, leading to preferential use of a downstream alternate splice donor site in intron 15, although some canonical splicing also occurred (Figure 3) 
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Prenatal Postnatal DNA in the variant transcript results in a frameshift, which would lead to premature termination (p.Asn563Valfs*16). While this transcript might be targeted for nonsense-mediated decay, any translated protein would also be non-functional given that this frameshift occurs at the start of the polymerase catalytic domain. Combined with a LoF mutation on the second allele, substantial reduction in POLE1 was therefore anticipated. Subsequent immunoblotting of total protein extracts from of primary fibroblasts from affected subjects confirmed that POLE1 levels were indeed markedly depleted (Figure 3 ; 5% 5 3% for P1 and 11% 5 4% P3, relative to the mean of both control subjects and normalized to vinculin loading control; mean 5 SD for n ¼ 2 independent experiments), with chromatin fractionation experiments demonstrating reduction of POLE1 in both soluble and chromatin-bound fractions ( Figure S4 ). Taken together with the consistent clinical phenotype across case subjects, we concluded that the identified POLE variants were pathogenic, resulting in a phenotype spectrum substantially overlapping IMAGe syndrome.
In keeping with an essential requirement for POLE in eukaryotes, 2 the ''leaky'' c.1686þ32C>G splice mutation permitted residual expression of functional POLE1 in all case subjects. This mutation in trans with truncating mutations would then be expected to lead to marked but partial loss of function. As POLE encodes POLE1, the catalytic subunit of the major leading-strand DNA polymerase Pol ε, reduced chromatin levels of POLE1 would therefore be expected to impact on the availability of Pol ε DNA polymerase activity during its canonical function in DNA replication. Consistent with this, time-course FACS analysis demonstrated delayed cell-cycle progression of BrdU-labeled primary fibroblasts from P1 and P3, indicative of impaired S-phase progression ( Figure 3) . While no viable model of POLE1 deficiency exists, a Pole4 À/À mouse has been generated, which is similarly deficient for the Pol ε holoenzyme. 17 This mouse also has significant prenatal onset growth failure, reduced brain size, and markedly reduced lymphocyte levels. Analysis of embryonic fibroblasts derived from this mouse alongside POLE primary human fibroblasts (derived from P1 and P3 in this study) established that in both cases Pol ε deficiency leads to reduced levels of chromatin-loaded Pol ε complexes, resulting in replication stress arising from reduced numbers of active replication origins. IMAGe syndrome has previously been found to be caused by dominant gain-of-function mutations in the imprinted gene, CDKN1C. 18, 19 Here, we establish mutations of POLE as an autosomal-recessive cause of the IMAGe phenotype. These mutations contrast with heterozygous germline and somatic cancer-predisposing mutations that affect the exonuclease domain of POLE1 [3] [4] [5] [6] (Figure 1 ).
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IMAGe and cancer mutations are likely to have differing functional outcomes, respectively leading to deficient DNA replication or to impaired proof-reading. 20 Hence, a similar cancer predisposition in POLE1-deficient individuals or POLE heterozygous carriers cannot be assumed. However, P5 developed a T cell lymphoma at age 11 and P15 developed Hodgkin's lymphoma at age 28. Given also the increased lymphoma rates in Pole4 À/À mice,
POLE1 deficiency may therefore confer an increased risk of lymphoma. All CDKN1C IMAGe mutations cluster within its proliferating cell nuclear antigen (PCNA) binding domain, 18, 19 targeting the PCNA binding PIP-box motif. 21 As PCNA loads with Pol ε at replication initiation (Figures 4 and  S5 Likewise, several families with GINS1 biallelic mutations have been reported to be associated with pre/postnatal growth restriction, chronic neutropenia, and NK cell deficiency (MIM: 610608). 10 Hence, the identification of a cohort of individuals with POLE mutations that encompasses all these features consolidates this as a group of replisome-associated disorders ( Figure 4 , Table S5 ). Replication stress and p53-mediated cell death 17 replication proteins during development, along with the cellular and biochemical basis for the relationship between CDKN1C and Pol ε, will therefore be of interest. 
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